Search results
What Is Ulcerative Colitis?
Verywell Health via Yahoo News· 1 year agoUlcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that primarily affects the large intestine (colon). There is currently no cure for...
Is Ulcerative Colitis an Autoimmune Disease?
Verywell Health via Yahoo News· 2 months agoMedically reviewed by Jay N. Yepuri, MD Ulcerative colitis is a type of inflammatory bowel disease (IBD). A problem with the immune system leads to...
Is Ulcerative Colitis Curable, or Is Symptom Remission Possible?
Verywell Health via Yahoo News· 6 months agoUlcerative colitis (UC) is a chronic inflammatory bowel disease (IBD). There is no known cure for...
Pfizer Has a New Oral Pill for Ulcerative Colitis
Verywell Health via Yahoo News· 6 months agoThe FDA approved Velsipity (etrasimod), a drug by Pfizer to treat ulcerative colitis. The approval adds another treatment option for patients who respond...
How Is Ulcerative Colitis Treated?
Health via Yahoo News· 2 weeks agoMaca and Naca / Getty Images Medically reviewed by Jay N. Yepuri, MD Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that affects the large intestine. Inflammation in the ...
The Surprise That Prompted Morphic Therapeutic To Dump 55% Over Two Days
Investor's Business Daily· 7 months agoMorphic Therapeutic stock plummeted Monday after tests showed the company's ulcerative colitis drug...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 6 days agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
What to Know About Pouchitis
Verywell Health via Yahoo News· 6 months agoPouchitis is an inflammation that occurs in some people who have had ileal pouch-anal anastomosis (IPAA) surgery. The surgery is often used to treat...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023...
Takeda Pharmaceutical’s Third-Quarter Net Profit Dropped on Lower Margins
The Wall Street Journal· 3 months agoNEWSPLUS Takeda Pharmaceutical reported a drop in its third-quarter net profit due partly to lower...